Captrust Financial Advisors
- SEC CIK
- 0001512024
- Latest filing
- Aug 13, 2026
ZNTL holding history
Zentalis Pharmaceuticals, Inc. in every 13F filed by Captrust Financial Advisors, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ZNTL overviewAll 13F holders of ZNTLFull Q2 2026 holdings
- Shares (Q4 2025)
- 0
- Sold out in Q4 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 0 | $0 | 0.0% | −10,464−100.0% | Sold out | Holders |
| Q3 2025 | 10,464 | $15.8K | <0.1% | −1,378−11.6% | Reduced | Holders |
| Q2 2025 | 11,842 | $13.7K | <0.1% | −4,103−25.7% | Reduced | Holders |
| Q1 2025 | 15,945 | $25.4K | <0.1% | +5,162+47.9% | Added | Holders |
| Q4 2024 | 10,783 | $32.7K | <0.1% | +10,783 | New | Holders |
| Q3 2022 | 0 | $0 | 0.0% | −750−100.0% | Sold out | Holders |
| Q2 2022 | 750 | $21.0K | <0.1% | −13−1.7% | Reduced | Holders |
| Q1 2022 | 763 | $35.0K | <0.1% | +758+15,160.0% | Added | Holders |
| Q4 2021 | 5 | $0 | 0.0% | +5 | New | Holders |